Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05548582 · ClinicalTrials.gov registry record · NA
Reduced Opioid Prescription After Laparoscopic Hysterectomy
A NA study of Pain and Pain, Postoperative, sponsored by Johns Hopkins University.
- Active
- Registry status
- NA
- Development phase
- 120
- Enrollment target
- 1
- Study location
NCT05548582: Active NA study of Pain and Pain, Postoperative, sponsored by Johns Hopkins University.
NCT05548582 is a NA study of Pain and Pain, Postoperative that is active but no longer recruiting, run by Johns Hopkins University. The registered enrollment target is 120 participants, below the 304-participant average among 374 other Pain trials with a reported enrollment target (61% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05548582, a NA study of Pain and Pain, Postoperative, is active but no longer recruiting, sponsored by Johns Hopkins University.
- ACTIVE NOT RECRUITING
- Registry status
- NA
- Development phase
- 120 participants
- Enrollment target
- 1
- Study location
Study Summary
Given the nationwide epidemic of opioid use and abuse (in part due to over prescription), this study aims at addressing the need for opioid prescription after laparoscopic hysterectomy.
Primary Outcome
Numeric pain score on post-operative day one: patient reported pain using the Likert pain scale from 0 to 10
Conditions Studied
Interventions
- DRUG Ibuprofen 600 mg
- DRUG OxyCODONE 5 mg Oral Tablet
- DRUG Acetaminophen 500 mg Tab
Study Locations (1)
Maryland
- Johns Hopkins Hospital - Baltimore
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 120 participants |
| Start Date | 2023-01-12 |
| Est. Completion | 2026-12-31 |
| Phase | NA |
What the registry record for NCT05548582 still lists
NCT05548582 is an interventional study that assigns participants to a tested intervention. The registered 120 participants enrollment target is mid-sized for trials with a published cap, below the 304-participant average among 374 other Pain trials with a reported enrollment target (61% lower).
The record links to 4 conditions, with Pain appearing as the primary indexed condition, and to 3 interventions - of which Ibuprofen 600 mg is the first listed.
NCT05548582 reports a single indexed study location in Maryland.
Frequently Asked Questions
What is clinical trial NCT05548582 about?
NCT05548582 is a clinical study titled "Reduced Opioid Prescription After Laparoscopic Hysterectomy". Given the nationwide epidemic of opioid use and abuse (in part due to over prescription), this study aims at addressing the need for opioid prescription after laparoscopic hysterectomy.
What is the current status of trial NCT05548582?
This trial is currently active not recruiting. It is a NA study. The enrollment target is 120 participants. The study started on 2023-01-12. Estimated completion is 2026-12-31.
What conditions does trial NCT05548582 study?
This clinical trial studies the following conditions: Pain, Pain, Postoperative, Opioid Use, Opioid Misuse.
What interventions are being tested in trial NCT05548582?
The interventions under investigation include: Ibuprofen 600 mg (DRUG), OxyCODONE 5 mg Oral Tablet (DRUG), Acetaminophen 500 mg Tab (DRUG).
Who is sponsoring clinical trial NCT05548582?
This trial is sponsored by Johns Hopkins University, which has 1,448 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05548582 being conducted?
This trial has 1 study location across Maryland. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Pain
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT05548582's enrollment target sits among peer trials
120 135th of 374 higher than 229 of 374 other Pain trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Pain trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Postoperative Pain After Activation of Irrigant
RECRUITING · NA
-
Neural Mechanisms of Immersive Virtual Reality in Chronic Pain (VR TMD EEG)
RECRUITING · NA
-
Pain With Dementia
RECRUITING · NA
-
Oklahoma Study of Native American Pain Risk IV: Smoking Cessation and Pain
RECRUITING · NA
-
Peer Support for Adolescents and Emerging Adults With Sickle Cell Pain
RECRUITING · NA
-
TENS Analgesia During Outpatient Urethral Bulking for Stress Urinary Incontinence.
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01174108 · 120 participants · Phase 2
Allogeneic Hematopoietic Stem Cell Transplantation for Severe Aplastic Anemia and Other Bone Marrow Failure Syndromes Using G-CSF Mobilized CD34+ Selected Hematopoietic Precursor Cells Co-Infused With a Reduced Dose of Non-Mobilized Donor T-cells
- NCT01627301 · 120 participants · NA
Sympathetic Overactivity in Post-traumatic Stress Disorder
- NCT02025023 · 120 participants · Phase 3
Local 5-Fluorouracil Injection for the Treatment of Chalazia: A Prospective, Comparative Study
- NCT02128906 · 120 participants · Phase 2
Radiotherapy With Cisplatin vs. Docetaxel-cetuximab in HNSCC: ERCC1 Biomarker Enrichment and Interaction Design
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI